Gynecology & Obstetrics (all articles)
Systematic Review | Maternal postures for fetal malposition in labor for improving the health of mothers and their infants.
14 Sep, 2022 | 13:12h | UTCSummary: Mothers’ positions in labour when baby is lying ‘back-to-back’ – Cochrane Library
Expert Opinion | Clinical management of pregnancy in women with polycystic ovary syndrome.
14 Sep, 2022 | 13:02h | UTC
Cluster RCT | Tighter vs. less tight glycemic targets for women with gestational diabetes mellitus for reducing maternal and perinatal morbidity.
13 Sep, 2022 | 13:21h | UTC
Systematic Review | Ultra‐radical (extensive) surgery vs. standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer.
13 Sep, 2022 | 12:56h | UTCRelated Study: Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer – New England Journal of Medicine
Guidelines for cancer treatment during pregnancy: ethics-related content evolution and implications for clinicians.
11 Sep, 2022 | 22:47h | UTC
Survey | Medical counseling on sexual enrichment aids: women’s preferences and medical practitioner expertise.
11 Sep, 2022 | 22:42h | UTC
Screening for high-risk human papillomavirus using passive, self-collected menstrual blood.
11 Sep, 2022 | 22:41h | UTCCommentary: Pap smears, be gone? Using menstrual blood to detect HPV – Stanford Medicine
Commentary on Twitter
FREE: Screening for High-Risk Human Papillomavirus Using Passive, Self-Collected Menstrual Blood #obgyn #HPV #GYN https://t.co/zLno2ab605 pic.twitter.com/mfPGjlTLdD
— The Green Journal (@greenjrnl) September 1, 2022
Study shows vaginal birth is feasible in some patients with low-lying placenta.
11 Sep, 2022 | 22:39h | UTCCommentary: Vaginal birth possible in 50% of women with low-lying placenta – MDedge
M-A | Performance of single serum progesterone in the evaluation of symptomatic first-trimester pregnant patients.
11 Sep, 2022 | 22:32h | UTCPerformance of single serum progesterone in the evaluation of symptomatic first-trimester pregnant patients: a systematic review and meta-analysis – Canadian Journal of Emergency Medicine (if the link is paywalled, try this one)
Cluster RCT | Umbilical cord milking may improve health in non-vigorous term and near-term infants.
8 Sep, 2022 | 14:47h | UTCNews Release: Umbilical cord milking may improve health in non-vigorous term and near-term infants – NIH News Releases
Original Study: Umbilical cord milking in non-vigorous infants: A cluster-randomized crossover trial – American Journal of Obstetrics & Gynecology (link to abstract – $ for full-text)
Commentary on Twitter
Does milking the umbilical cord benefit infants non-vigorous at birth?
A new RCT by @NeoAnup published in @AJOG_thegray evaluates this https://t.co/M5RRAzdEHz#neoEBM #neoTwitter #EBNEOAlerts pic.twitter.com/mZnSKjcGNt
— Evidence-Based Neo (@EBNEO) August 20, 2022
Cohort Study | Children conceived via assisted reproductive technologies are at increased risk of childhood cancers.
7 Sep, 2022 | 12:32h | UTCAssisted Reproductive Technology and Risk of Childhood Cancers – JAMA Network Open
Invited Commentary: Fertility Treatment and Childhood Cancer Risk – JAMA Network Open
Commentary on Twitter
Children born of assisted reproductive technology (ART) conception was associated with an increased risk of overall childhood cancers compared with those conceived naturally and those with subfertility and non-ART conception. #OpenAccess #Research https://t.co/HylUVE4gFg
— JAMA Network Open (@JAMANetworkOpen) August 31, 2022
Cohort Study | Fertility preservation procedures appear to be safe at the time of breast cancer diagnosis.
7 Sep, 2022 | 12:31h | UTCNews Release: Fertility preservation measures do not appear to increase the risk of breast cancer recurrence – Karolinska Institutet
Cohort Study | Associations between maternal antenatal corticosteroid treatment and psychological developmental and neurosensory disorders in children.
6 Sep, 2022 | 14:26h | UTCCommentary: Toxicity of antenatal steroids on the developing brain – Neonatal Research
Commentary on Twitter
Maternal antenatal corticosteroid treatment-exposure, compared with nonexposure, was associated with higher rates of psychological development and neurosensory disorders in children followed from birth through 12 years of age. #OAResearch https://t.co/PuVSBTASze
— JAMA Network Open (@JAMANetworkOpen) August 24, 2022
Systematic Review | Luteal phase support for women trying to conceive by intrauterine insemination or sexual intercourse.
2 Sep, 2022 | 13:08h | UTC
Commentary on Twitter
❓ What is the effectiveness and safety of luteal support for those trying to conceive by intrauterine insemination #IUI or by sexual intercourse?
New @CochraneCGF systematic review looks at the evidence from 25 RCTs involving 5,111 participants. https://t.co/jjsetCMo3E pic.twitter.com/tWNtGx8rdC— The Cochrane Library (@CochraneLibrary) September 2, 2022
Systematic Review | Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine‐device use.
2 Sep, 2022 | 13:07h | UTC
Cohort Study | Dolutegravir in pregnancy as compared with current HIV regimens.
1 Sep, 2022 | 11:55h | UTCDolutegravir in Pregnancy as Compared with Current HIV Regimens in the United States – New England Journal of Medicine (link to abstract – $ for full-text)
Related:
RCT | 72 weeks post-partum follow-up of dolutegravir versus efavirenz initiated in late pregnancy.
WHO Recommends Dolutegravir as Preferred HIV Treatment Option in All Populations
RCT: Dolutegravir or Darunavir in combination with Zidovudine or Tenofovir to treat HIV.
Commentary on Twitter
In this study involving 1257 pregnancies among persons treated for HIV-1 infection during pregnancy, dolutegravir was better at suppressing viral loads than other regimens, without evident safety concerns. https://t.co/CnShoao995 pic.twitter.com/Qne24I1482
— NEJM (@NEJM) August 31, 2022
RCT | Placement of an intrauterine device within 48 hours after early medical abortion.
1 Sep, 2022 | 11:51h | UTC
Cohort Study | 5-year follow-up results suggest it is safe to de-escalate radiotherapy after primary chemotherapy in cT1–2N1 breast cancer.
31 Aug, 2022 | 11:45h | UTCDe-escalation of radiotherapy after primary chemotherapy in cT1–2N1 breast cancer (RAPCHEM; BOOG 2010–03): 5-year follow-up results of a Dutch, prospective, registry study – The Lancet Oncology (link to abstract – $ for full-text)
Commentary on Twitter
At 5-year follow up in RAPCHEM, BOOG 2010–03 study of locoregional RT de-escalation in cT1-2N1 breast cancer, locoregional recurrence rates were 2.3%, 1.0% and 1.4% in low, intermediate and high risk groups, and therefore this approach was considered safe: https://t.co/4NkUwr4kxV
— NatureRevClinOncol (@NatRevClinOncol) August 15, 2022
Relationship between maternal caffeine and coffee intake and pregnancy loss: a grading of recommendations assessment, development, and evaluation-assessed, dose-response meta-analysis of observational studies.
31 Aug, 2022 | 11:35h | UTC
Study shows an increasing incidence of hypertensive disorders in pregnancy.
30 Aug, 2022 | 11:52h | UTCCommentaries:
Increased incidence of hypertensive disorders of pregnancy in young Americans – News Medical
Hypertensive Disorders in Pregnancy on the Rise – AJMC
Commentary on Twitter
Independent birth cohort effect on rates of hypertensive disorders of pregnancy higher incidence in younger generations and persistent racial and ethnic disparities. Increased awareness even among young pregnant people is needed. #OAResearch https://t.co/wNwIZTYLHZ
— JAMA Network Open (@JAMANetworkOpen) August 24, 2022
M-A | Adverse pregnancy and birth outcomes associated with Mycoplasma hominis, Ureaplasma urealyticum and Ureaplasma parvum.
29 Aug, 2022 | 12:06h | UTC
A simple cervicovaginal epigenetic test for screening and rapid triage of women with suspected endometrial cancer: validation in several cohort and case/control sets.
29 Aug, 2022 | 11:58h | UTC
Commentary on Twitter
Pleased to share our work out today in J Clin Oncol "A Simple Cervicovaginal Epigenetic Test for Screening and Rapid Triage of Women With Suspected Endometrial Cancer …" #FORECEE #CCBIO #H2020 @eveappeal @Gynkreft @medofak_uib @haukeland_no
#screening https://t.co/Av53WSWqoQ pic.twitter.com/dL4j7nW7vt— Line Bjørge (@DrLB) August 24, 2022
Under a https://creativecommons.org/licenses/by/4.0/ license
RCT | HPV self-sampling among long-term non-attenders to cervical cancer screening.
26 Aug, 2022 | 13:27h | UTC
Commentary on Twitter
Pragmatic randomised controlled trial of 3 different HPV screening approaches suggests that opt-in and particularlly send-to-all self-sampling increased participation among long-term, higher-risk non-attenders: https://t.co/hBouqoBMnU #GynCSM #hsronc
— NatureRevClinOncol (@NatRevClinOncol) August 25, 2022
Endocervical sampling in women with suspected cervical neoplasia: a systematic review and meta-analysis of diagnostic test accuracy studies.
26 Aug, 2022 | 13:18h | UTC
Systematic Review | Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
26 Aug, 2022 | 13:11h | UTC